Galapagos NV (LTS:0JXZ)
€ 25.21 -0.28 (-1.1%) Market Cap: 1.66 Bil Enterprise Value: -1.67 Bil PE Ratio: 8.03 PB Ratio: 0.58 GF Score: 55/100

Galapagos NV at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 02:10PM GMT
Release Date Price: €82.89 (-0.29%)
James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, and good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today at the JPMorgan Healthcare Conference, it's my pleasure to introduce Onno van de Stolpe, CEO of Galapagos for this presentation. So we're going to have a 20-minute presentation from Onno, and then we're going to have 20 minutes for your questions. And we're going to be joined by the Board of Galapagos management team. We've got the whole gang. So look forward to that. And you can immediately start registering your questions and the way you do this is with the Q&A function that's associated with this presentation on the conference website. And then I'm going to be reading your questions on the presentation from there.

So with that said, I'd like to welcome Onno and Galapagos at the conference, and I look forward to the presentation.

Onno Van De Stolpe
Galapagos NV - Co-Founder, Chairman of the Management Board, MD & CEO

Thank you, James. It's a pleasure to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot